Related Experiment Video
Updated: May 26, 2026

05:18
A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering
Published on: December 7, 2016
Performance Evaluation of a Premier Resolution HPLC System for Detecting Hemoglobin Constant Spring, Hemoglobin
Surada Satthakarn1, Wibhasiri Srisuwan2, Sitthichai Panyasai2
1Department of Medical Technology, Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.
Journal of Clinical Laboratory Analysis
|May 25, 2026
Summary
Premier Resolution HPLC effectively detects Hemoglobin Constant Spring (HbCS) and Hb Paksé, outperforming capillary electrophoresis for thalassemia screening. This method offers improved accuracy, especially in high-prevalence regions.
Area of Science:
- Hematology
- Clinical Chemistry
- Genetics
Background:
- Hemoglobin Constant Spring (HbCS) and Hb Paksé are prevalent α-globin variants in Southeast Asia.
- These variants, when combined with α0-thalassemia, cause severe HbH disease.
- Their instability and low levels challenge conventional screening, leading to false negatives.
Purpose of the Study:
- To evaluate Premier Resolution High-Performance Liquid Chromatography (HPLC) for detecting HbCS and Hb Paksé.
- To compare its performance against capillary electrophoresis (CE).
- To characterize chromatographic patterns across different α- and β-globin genotypes.
Main Methods:
- A two-phase validation study involving 616 samples (Phase 1) and 2,032 individuals (Phase 2).
- Comparison of Premier Resolution HPLC with CE using DNA-confirmed cases.
- Molecular analysis served as the reference standard.
Main Results:
- Premier Resolution HPLC showed distinctive multi-peak patterns for HbCS/Hb Paksé.
- It demonstrated higher sensitivity (96.4%) and specificity (97.1%) than CE (92.8% sensitivity, 93.5% specificity).
- False negatives were reduced, particularly in heterozygotes, though heterozygous Hb Paksé remained undetectable by both methods.
Conclusions:
- Premier Resolution HPLC is a reliable and cost-effective method for HbCS detection in populations at risk for α-thalassemia.
- Its enhanced resolution aids routine screening in high-prevalence areas.
- Molecular confirmation is still essential for heterozygous cases and genetic counseling.
